Literature DB >> 26279266

Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.

ChangHui Pak1, Tamas Danko2, Yingsha Zhang1, Jason Aoto1, Garret Anderson1, Stephan Maxeiner1, Fei Yi1, Marius Wernig3, Thomas C Südhof4.   

Abstract

Heterozygous mutations of the NRXN1 gene, which encodes the presynaptic cell-adhesion molecule neurexin-1, were repeatedly associated with autism and schizophrenia. However, diverse clinical presentations of NRXN1 mutations in patients raise the question of whether heterozygous NRXN1 mutations alone directly impair synaptic function. To address this question under conditions that precisely control for genetic background, we generated human ESCs with different heterozygous conditional NRXN1 mutations and analyzed two different types of isogenic control and NRXN1 mutant neurons derived from these ESCs. Both heterozygous NRXN1 mutations selectively impaired neurotransmitter release in human neurons without changing neuronal differentiation or synapse formation. Moreover, both NRXN1 mutations increased the levels of CASK, a critical synaptic scaffolding protein that binds to neurexin-1. Our results show that, unexpectedly, heterozygous inactivation of NRXN1 directly impairs synaptic function in human neurons, and they illustrate the value of this conditional deletion approach for studying the functional effects of disease-associated mutations.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autism; human neurons; iN cells; neurexin; schizophrenia; synapse; synaptic cell adhesion

Mesh:

Substances:

Year:  2015        PMID: 26279266      PMCID: PMC4560990          DOI: 10.1016/j.stem.2015.07.017

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  50 in total

1.  Calmodulin suppresses synaptotagmin-2 transcription in cortical neurons.

Authors:  Zhiping P Pang; Wei Xu; Peng Cao; Thomas C Südhof
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.

Authors:  Julie Gauthier; Tabrez J Siddiqui; Peng Huashan; Daisaku Yokomaku; Fadi F Hamdan; Nathalie Champagne; Mathieu Lapointe; Dan Spiegelman; Anne Noreau; Ronald G Lafrenière; Ferid Fathalli; Ridha Joober; Marie-Odile Krebs; Lynn E DeLisi; Laurent Mottron; Eric Fombonne; Jacques L Michaud; Pierre Drapeau; Salvatore Carbonetto; Ann Marie Craig; Guy A Rouleau
Journal:  Hum Genet       Date:  2011-03-22       Impact factor: 4.132

Review 3.  The genomics of schizophrenia: update and implications.

Authors:  Paola Giusti-Rodríguez; Patrick F Sullivan
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

4.  Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing.

Authors:  Barbara Treutlein; Ozgun Gokce; Stephen R Quake; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

5.  CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes.

Authors:  Anna Hackett; Patrick S Tarpey; Andrea Licata; James Cox; Annabel Whibley; Jackie Boyle; Carolyn Rogers; John Grigg; Michael Partington; Roger E Stevenson; John Tolmie; John Rw Yates; Gillian Turner; Meredith Wilson; Andrew P Futreal; Mark Corbett; Marie Shaw; Jozef Gecz; F Lucy Raymond; Michael R Stratton; Charles E Schwartz; Fatima E Abidi
Journal:  Eur J Hum Genet       Date:  2009-12-23       Impact factor: 4.246

Review 6.  Modeling human neurological disorders with induced pluripotent stem cells.

Authors:  Yoichi Imaizumi; Hideyuki Okano
Journal:  J Neurochem       Date:  2013-12-15       Impact factor: 5.372

Review 7.  Recent developments in the genetics of autism spectrum disorders.

Authors:  John D Murdoch; Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2013-03-25       Impact factor: 5.578

8.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

9.  Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.

Authors:  Sara E Howden; Athurva Gore; Zhe Li; Ho-Lim Fung; Benjamin S Nisler; Jeff Nie; Goukai Chen; Brian E McIntosh; Daniel R Gulbranson; Nicole R Diol; Seth M Taapken; David T Vereide; Karen Dyer Montgomery; Kun Zhang; David M Gamm; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

Review 10.  Balance within the Neurexin Trans-Synaptic Connexus Stabilizes Behavioral Control.

Authors:  Raymond A Clarke; Valsamma Eapen
Journal:  Front Hum Neurosci       Date:  2014-02-27       Impact factor: 3.169

View more
  91 in total

Review 1.  Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.

Authors:  Marliette R Matos; Seok-Man Ho; Nadine Schrode; Kristen J Brennand
Journal:  Mol Cell Neurosci       Date:  2020-07-23       Impact factor: 4.314

2.  Carbonic anhydrase-related protein CA10 is an evolutionarily conserved pan-neurexin ligand.

Authors:  Fredrik H Sterky; Justin H Trotter; Sung-Jin Lee; Christian V Recktenwald; Xiao Du; Bo Zhou; Peng Zhou; Jochen Schwenk; Bernd Fakler; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-01       Impact factor: 11.205

3.  CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks.

Authors:  Eric Deneault; Muhammad Faheem; Sean H White; Deivid C Rodrigues; Song Sun; Wei Wei; Alina Piekna; Tadeo Thompson; Jennifer L Howe; Leon Chalil; Vickie Kwan; Susan Walker; Peter Pasceri; Frederick P Roth; Ryan Kc Yuen; Karun K Singh; James Ellis; Stephen W Scherer
Journal:  Elife       Date:  2019-02-12       Impact factor: 8.140

Review 4.  New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids.

Authors:  John D Blair; Helen S Bateup
Journal:  Dev Dyn       Date:  2019-05-23       Impact factor: 3.780

5.  Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity.

Authors:  Soham Chanda; Cheen Euong Ang; Qian Yi Lee; Michael Ghebrial; Daniel Haag; Yohei Shibuya; Marius Wernig; Thomas C Südhof
Journal:  Cell Stem Cell       Date:  2019-05-30       Impact factor: 24.633

Review 6.  Neural Subtype Specification from Human Pluripotent Stem Cells.

Authors:  Yunlong Tao; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2016-11-03       Impact factor: 24.633

7.  Structural Plasticity of Neurexin 1α: Implications for its Role as Synaptic Organizer.

Authors:  Jianfang Liu; Anurag Misra; M V V V Sekhar Reddy; Mark Andrew White; Gang Ren; Gabby Rudenko
Journal:  J Mol Biol       Date:  2018-09-05       Impact factor: 5.469

8.  Two microcephaly-associated novel missense mutations in CASK specifically disrupt the CASK-neurexin interaction.

Authors:  Leslie E W LaConte; Vrushali Chavan; Abdallah F Elias; Cynthia Hudson; Corbin Schwanke; Katie Styren; Jonathan Shoof; Fernando Kok; Sarika Srivastava; Konark Mukherjee
Journal:  Hum Genet       Date:  2018-02-09       Impact factor: 4.132

9.  Analysis of conditional heterozygous STXBP1 mutations in human neurons.

Authors:  Christopher Patzke; Yan Han; Jason Covy; Fei Yi; Stephan Maxeiner; Marius Wernig; Thomas C Südhof
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

Review 10.  Applications of CRISPR-Cas systems in neuroscience.

Authors:  Matthias Heidenreich; Feng Zhang
Journal:  Nat Rev Neurosci       Date:  2015-12-10       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.